Largest pharmaceutical companies by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Johnson & Johnson leads the 52 pharmaceutical companies ranked by revenue, at SEK 957.5B, ahead of Eli Lilly (SEK 662.6B) and Merck & Co (SEK 660.9B). Figures as of 18 Nov 2026, 19:11 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 52
- First
- Johnson & JohnsonSEK 957.5B
- Median
- SEK 32.5B
- Combined market value
- SEK 51.58T
- Countries
- 10
- Not ranked
- 9no revenue on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | SEK 957.5B | SEK 6.71T | SEK 2,788.17 | 1.59% down | 38% up | ||
| 2 | Eli LillyLLY · Health Care | SEK 662.6B | SEK 12.58T | SEK 14,119.50 | 1.88% down | 35% up | ||
| 3 | Merck & CoMRK · Health Care | SEK 660.9B | SEK 3.45T | SEK 1,400.82 | 3.89% down | 51% up | ||
| 4 | PfizerPFE · Health Care | SEK 636.2B | SEK 1.63T | SEK 285.50 | 1.35% down | 14% up | ||
| 5 | AbbVieABBV · Health Care | SEK 621.7B | SEK 5.15T | SEK 2,916.30 | 2.03% down | 26% up | ||
| 6 | AstraZenecaAZN · Health Care | SEK 597.1B | SEK 2.82T | SEK 1,819.18 | 1.82% down | 2% up | ||
| 7 | NovartisNVS · Health Care | SEK 554.3B | SEK 2.99T | SEK 1,581.51 | 2.23% down | 25% up | ||
| 8 | SanofiSNY · Health Care | SEK 492B | SEK 1.15T | SEK 480.43 | 0.57% down | 4% down | ||
| 9 | Bristol-Myers SquibbBMY · Health Care | SEK 489.9B | SEK 1.25T | SEK 609.12 | 2.33% down | 34% up | ||
| 10 | Novo NordiskNVO · Health Care | SEK 466.2B | SEK 1.77T | SEK 401.79 | 2.89% down | 17% down | ||
| 11 | Abbott LaboratoriesABT · Health Care | SEK 450.6B | SEK 1.84T | SEK 1,062.20 | 0.21% down | 17% down | ||
| 12 | GSKGSK · Health Care | SEK 440.8B | SEK 991.5B | SEK 494.66 | 1.18% down | 6% up | ||
| 13 | Takeda PharmaceuticalTAK · Health Care | SEK 286.9B | SEK 693.1B | SEK 216.93 | 1.39% down | 54% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | SEK 175.4B | SEK 499B | SEK 427.62 | 1.30% down | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | SEK 145.8B | SEK 994B | SEK 9,608.62 | 1.31% down | 36% up | ||
| 16 | ViatrisVTRS · Health Care | SEK 145.4B | SEK 240.3B | SEK 209.56 | 0.81% up | 96% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | SEK 122B | SEK 1.39T | SEK 5,469.60 | 0.72% up | 27% up | ||
| 18 | ZoetisZTS · Health Care | SEK 96.2B | SEK 353.2B | SEK 869.16 | 2.42% up | 29% down | ||
| 19 | GrifolsGRFS · Health Care | SEK 84.9B | SEK 58.3B | SEK 85.65 | 2.38% down | 1% up | ||
| 20 | BeOne MedicinesONC · Health Care | SEK 54.3B | SEK 469.3B | SEK 4,108.32 | 2.21% down | 17% up | ||
| 21 | Elanco Animal HealthELAN · Health Care | SEK 47.9B | SEK 136.7B | SEK 273.56 | 4.10% up | 20% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | SEK 43.4B | SEK 160.7B | SEK 2,502.87 | 2.28% up | 37% up | ||
| 23 | GenmabGMAB · Health Care | SEK 37.8B | SEK 321.6B | SEK 521.60 | 1.25% down | 70% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | SEK 37.8B | SEK 203.1B | SEK 1,516.71 | 4.66% down | 66% down | ||
| 25 | Dr. Reddy's LaboratoriesRDY · Health Care | SEK 36.3B | SEK 127.4B | SEK 152.84 | 1.66% up | 5% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | SEK 32.7B | SEK 119.7B | SEK 617.97 | 3.90% up | 11% up | ||
| 27 | United TherapeuticsUTHR · Health Care | SEK 32.4B | SEK 251.6B | SEK 5,908.34 | 0.49% down | 23% up | ||
| 28 | Amneal PharmaceuticalsAMRX · Health Care | SEK 30.7B | SEK 77.8B | SEK 223.39 | 4.05% up | 83% up | ||
| 29 | Royalty PharmaRPRX · Health Care | SEK 24.2B | SEK 405.2B | SEK 704.63 | 0.92% up | 78% up | ||
| 30 | PTC TherapeuticsPTCT · Health Care | SEK 17.6B | SEK 51.1B | SEK 611.71 | 0.31% down | 20% down | ||
| 31 | AlkermesALKS · Health Care | SEK 15B | SEK 79.6B | SEK 473.41 | 2.46% up | 58% up | ||
| 32 | Legend BiotechLEGN · Health Care | SEK 10.5B | SEK 31.9B | SEK 164.28 | 0.31% up | 42% down | ||
| 33 | Madrigal PharmaceuticalsMDGL · Health Care | SEK 9.7B | SEK 94.7B | SEK 4,078.28 | 4.93% down | 24% down | ||
| 34 | Ionis PharmaceuticalsIONS · Health Care | SEK 9.6B | SEK 47.1B | SEK 282.71 | 3.15% up | 64% down | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | SEK 8.4B | SEK 62.2B | SEK 439.76 | 0.63% up | 10% up | ||
| 36 | Ascendis PharmaASND · Health Care | SEK 8.1B | SEK 180.6B | SEK 2,752.59 | 0.15% down | 28% up | ||
| 37 | Corcept TherapeuticsCORT · Health Care | SEK 7.7B | SEK 75.4B | SEK 689.13 | 3.25% down | 8% down | ||
| 38 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SEK 6.9B | SEK 76B | SEK 966.66 | 0.02% down | 126% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | SEK 6.5B | SEK 71.5B | SEK 1,358.68 | 1.69% down | 7% down | ||
| 40 | TG TherapeuticsTGTX · Health Care | SEK 6.3B | SEK 101.2B | SEK 669.40 | 5.01% up | 107% up | ||
| 41 | InsmedINSM · Health Care | SEK 6.2B | SEK 268.3B | SEK 1,222.97 | 1.28% down | 40% down | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | SEK 5.3B | SEK 61B | SEK 933.91 | 0.09% down | 31% up | ||
| 43 | BridgeBio PharmaBBIO · Health Care | SEK 5.1B | SEK 154B | SEK 790.63 | 1.27% up | 17% up | ||
| 44 | Travere TherapeuticsTVTX · Health Care | SEK 5B | SEK 49.5B | SEK 515.70 | 0.72% down | 44% up | ||
| 45 | Ligand PharmaceuticalsLGND · Health Care | SEK 2.7B | SEK 61.2B | SEK 3,057.35 | 2.36% up | 43% up | ||
| 46 | Rhythm PharmaceuticalsRYTM · Health Care | SEK 1.9B | SEK 84.8B | SEK 1,222.51 | 3.13% up | 13% up | ||
| 47 | CytokineticsCYTK · Health Care | SEK 895M | SEK 72.3B | SEK 519.26 | 1.10% down | 20% down | ||
| 48 | Protagonist TherapeuticsPTGX · Health Care | SEK 467.8M | SEK 83.3B | SEK 1,275.88 | 0.67% up | 46% up | ||
| 49 | Roivant SciencesROIV · Health Care | SEK 84M | SEK 282.7B | SEK 390.16 | 0.85% down | 90% up | ||
| 50 | Dianthus TherapeuticsDNTH · Health Care | SEK 20.7M | SEK 49.5B | SEK 879.12 | 0.57% down | 113% up | ||
| 51 | Spyre TherapeuticsSYRE · Health Care | SEK 0 | SEK 93B | SEK 978.95 | 2.65% up | 286% up | ||
| 52 | Praxis Precision MedicinesPRAX · Health Care | SEK 0 | SEK 87B | SEK 3,112.30 | 0.36% up | 61% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1656 SEK). 9 companies have no revenue on file and are not ranked here.
Questions and answers
Which pharmaceutical companies rank first by revenue?
Johnson & Johnson (SEK 957.5B), Eli Lilly (SEK 662.6B) and Merck & Co (SEK 660.9B) are the top three of the 52 pharmaceutical companies ranked by revenue as of 18 Nov 2026, 19:11 UTC.
How many pharmaceutical companies are in this ranking?
52 are ranked by revenue. 9 more have no revenue on file and are left out rather than ranked at zero.
What are these pharmaceutical companies worth together?
The 52 pharmaceutical companies ranked by revenue have a combined market value of SEK 51.58T as of 18 Nov 2026, 19:11 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies by revenue”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.